Insider Transactions in Q1 2023 at Cti Biopharma Corp (CTIC)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 24
2023
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
85,317
-40.29%
|
$511,902
$6.01 P/Share
|
|
Jan 24
2023
|
Adam R Craig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
85,317
+24.39%
|
$0
$0.84 P/Share
|
|
Jan 24
2023
|
James K Fong EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
100,000
-96.56%
|
$600,000
$6.0 P/Share
|
|
Jan 24
2023
|
James K Fong EVP & Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+49.12%
|
$0
$0.95 P/Share
|
|
Jan 03
2023
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
84,683
-74.2%
|
$508,098
$6.01 P/Share
|
|
Jan 03
2023
|
Adam R Craig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
84,683
+42.6%
|
$0
$0.84 P/Share
|
|
Jan 03
2023
|
David Kirske EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,021
-61.21%
|
$162,126
$6.01 P/Share
|
|
Jan 03
2023
|
David Kirske EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,021
+37.97%
|
$0
$0.95 P/Share
|